With Hologic, Inc. HOLX gearing up to release its fiscal 2025 first-quarter financial results on Feb. 5 after the market ...

Shares of Hologic Inc. HOLX shed 1.35% to $71.77 Tuesday, on what proved to be an all-around favorable trading session for ...

This was the stock's second consecutive day of gains.

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $70.37 which represents a slight increase of $0.64 or 0.92% from the prior close of $69.73. The stock opened at $69.98 and touched a low ...

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store. Hologic stopped manufacturing the device after ...

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $71.02 which represents a slight increase of $0.32 or 0.45% from the prior close of $70.7. The stock opened at $70.45 and touched a low ...

Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even though the company recalled the devices last year.

Investment analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for shares of Hologic in a research note issued on ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Hologic, Inc. has a 1 year low of $68.61 and a 1 year high of $84.67. Hologic ( NASDAQ:HOLX – Get Free Report ) last announced its quarterly earnings data on Monday, November 4th.